Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $4.19 Million - $4.86 Million
31,400 Added 234.33%
44,800 $6.68 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $1.78 Million - $2.21 Million
13,400 New
13,400 $1.81 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alphadyne Asset Management LP Portfolio

Follow Alphadyne Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphadyne Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Alphadyne Asset Management LP with notifications on news.